Aspira Pathlab & Diagnostics Board to Consider Fundraising on 12th Sep'26
Aspira Pathlab & Diagnostics Ltd 路 Intimation 路 07 Sept 2026, 7:15 pm
Aspira Pathlab & Diagnostics Board to Consider Fundraising on 12th Sep'26 Aspira Pathlab & Diagnostics Limited has scheduled a Board of Directors meeting for 12th Sep'26 to evaluate and approve fundraising proposals. The capital raise is contemplated via the issuance of equity shares, convertible warrants, or other permissible instruments through preferential issue, private placement, rights issue, or other eligible methods, subject to requisite shareholder and statutory approvals.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
